Results 41 to 50 of about 358,804 (264)

Incidence and Severity of Carboplatin‐Associated Hearing Loss in Children With Cancer Assessed by the SIOP Boston 2012 Ototoxicity Criteria

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Platinum‐based chemotherapy is known to cause severe and debilitating hearing loss, but unlike cisplatin, the true incidence of carboplatin‐induced hearing loss remains unclear. We evaluated functional hearing outcomes in children receiving carboplatin to determine the incidence and severity of ototoxicity. Procedure We identified a
Aniket Chawla, Sean Carter, Andrew Wood, Sandra Staffieri, Andrew Dodgshun, David D. Eisenstat, Michael Sullivan   +6 more
wiley   +1 more source

SOFTWARE TOOL FOR LOGICAL VALIDATION OF CRYPTOGRAPHIC KEY GENERATION PROTOCOLS BASED ON BAN-LOGIC

Advanced Engineering Research, 2012
The idea of analyzing cryptographic key generation protocols through BAN - logic methods is considered. An e xample of Kerberos protocol analysis is given. The software tool that automates the analysis of key g eneration protocols is built.
Nadezhda S. Mogilevskaya
doaj  

RSRP: A Robust Secure Routing Protocol in MANET

Foundations of Computing and Decision Sciences, 2014
In this paper, we propose a novel algorithm RSRP to build a robust secure routing protocol in mobile ad-hoc networks (MANETs). This algorithm is based on some basic schemes such as RSA_CRT for encryption and decryption of messages; CRT for safety key ...
Sinha Ditipriya, Bhattacharya Uma, Chaki Rituparna   +2 more
doaj   +1 more source

A Decentralized Lightweight Authentication and Privacy Protocol for Vehicular Networks

IEEE Access, 2019
Recently many security protocols have been proposed for road safety applications in Vehicle-to-everything (V2X) communications. Most of them, however, do not fully satisfy the requirements of light-weight and fast processing, which are special properties
Shimaa A. Abdel Hakeem, Mohamed A. Abd El-Gawad, HyungWon Kim   +2 more
doaj   +1 more source

Cooperative Power-Domain NOMA Systems: An Overview

Sensors, 2022
Interference has been a key roadblock against the effectively deployment of applications for end-users in wireless networks including fifth-generation (5G) and beyond fifth-generation (B5G) networks.
Mujtaba Ghous, Ahmad Kamal Hassan, Ziaul Haq Abbas, Ghulam Abbas, Aseel Hussien, Thar Baker   +5 more
doaj   +1 more source

Association Between Dinutuximab Beta Exposure and Post‐End‐of‐Treatment Survival in Neuroblastoma: A Weighted Patient‐Level Analysis of Three Clinical Studies

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Objectives The association between exposure to dinutuximab beta (DB) and event‐free survival (EFS) or overall survival (OS) of neuroblastoma patients was assessed using data collected during three clinical trials (five cohorts). Methods A systematic review (March 2026) was conducted to identify relevant studies (prospective; registered DB ...
Przemysław Holko, Holger N. Lode, Alberto Garaventa, Carla Manzitti, Roberto Luksch, Dominique Valteau‐Couanet, Marion Gambart, John Anderson, Juliet Gray, Adela Canete, Lucas Moreno, Aleksandra Wieczorek, Cormac Owens, Shifra Ash, Isaac Yaniv, Genevieve Laureys, Hans Loibner, Katarzyna Śladowska, Ruth Ladenstein, Paweł Kawalec   +19 more
wiley   +1 more source

Comparison of two lab-scale protocols for enhanced mRNA-based CAR-T cell generation and functionality

Scientific Reports, 2023
Process development for transferring lab-scale research workflows to automated manufacturing procedures is critical for chimeric antigen receptor (CAR)-T cell therapies.
Nadine von Auw, Robert Serfling, Reni Kitte, Nadja Hilger, Chengkang Zhang, Clara Gebhardt, Anna Duenkel, Paul Franz, Ulrike Koehl, Stephan Fricke, U. Sandy Tretbar   +10 more
doaj   +1 more source

Long‐Term Outcomes of Patients With Relapsed/Refractory Neuroblastoma Treated on ANBL1221: A Report From the Children's Oncology Group

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Results of COG ANBL1221 changed treatment paradigms for patients with relapsed/refractory neuroblastoma. Chemoimmunotherapy with irinotecan/temozolomide/dinutuximab is now used as both bridge therapy following suboptimal response to induction and as treatment in first relapse.
Elizabeth Sokol, Arlene Naranjo, Lulu Chen, Rajen Mody, Steven G. DuBois, Rochelle Bagatell, Navin Pinto   +6 more
wiley   +1 more source

Survival by Race and Ethnicity in Children and Adolescents/Young Adults With Relapsed/Refractory Hodgkin Lymphoma: A Pooled Analysis of Children's Oncology Group Trials

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Despite 5‐year survival rates of over 90% among children and adolescents/young adults (CAYAs) with classic Hodgkin lymphoma (cHL), 15%–20% relapse after frontline therapy. Prior analysis of frontline Children's Oncology Group (COG) clinical trials demonstrated that, despite similar rates of relapse, non‐Hispanic Black (NHB) and ...
Mallorie B. Heneghan, Lindsay A. Renfro, Yue Wu, Katia M. Crisler, Erin Marcotte, Tanya Trippett, Terzah Horton, Bradford S. Hoppe, Frank G. Keller, Chris Forlenza, Cindy Schwartz, Kara M. Kelly, Peter D. Cole, Sharon M. Castellino, Justine M. Kahn   +14 more
wiley   +1 more source

Quantum key distribution through quantum machine learning: a research review

Frontiers in Quantum Science and Technology
Quantum cryptography has emerged as a radical research field aimed at mitigating various security threats in modern communication systems. The integration of Quantum Machine Learning (QML) protocols plays a crucial role in enhancing security measures ...
Krupa Purohit, Ajay Kumar Vyas
doaj   +1 more source